EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Profiling the Interaction between Human Serum Albumin and Clinically Relevant HIV Reverse Transcriptase Inhibitors

Andreia Costa-Tuna iD, Otávio A Chaves iD, Zaida L Almeida iD, Rita S Cunha, João Pina iD, Carlos Serpa iD

Viruses · 2024

DOI: 10.3390/v16040491 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Andreia Costa-Tuna und 5 weiteren Autor:innen. Beteiligte Einrichtung: CQC-IMS, Department of Chemistry, University of Coimbra, Rua Larga, 3004-535 Coimbra, Portugal. Hauptthemen laut MEDLINE: Reverse Transcriptase Inhibitors, Tenofovir, Serum Albumin, Human, Protein Binding. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e Tecnologia, Fundação para a Ciência e a Tecnologia (FCT—Portuguese Agency for Scientific Research).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tenofovir (TFV) is the active form of the prodrugs tenofovir disoproxil fumarate (TDF) and tenofovir alafenamide (TAF), both clinically prescribed as HIV reverse transcriptase inhibitors. The biophysical interactions between these compounds and human serum albumin (HSA), the primary carrier of exogenous compounds in the human bloodstream, have not yet been thoroughly characterized. Thus, the present study reports the interaction profile between HSA and TFV, TDF, and TAF via UV–Vis, steady-state, and time-resolved fluorescence techniques combined with isothermal titration calorimetry (ITC) and in silico calculations. A spontaneous interaction in the ground state, which does not perturb the microenvironment close to the Trp-214 residue, is classified as weak. In the case of HSA/TFV and HSA/TDF, the binding is both enthalpically and entropically driven, while for HSA/TAF, the binding is only entropically dominated. The binding constant (Ka) and thermodynamic parameters obtained via ITC assays agree with those obtained using steady-state fluorescence quenching measurements, reinforcing the reliability of the data. The small internal cavity known as site I is probably the main binding pocket for TFV due to the low steric volume of the drug. In contrast, most external sites (II and III) can better accommodate TAF due to the high steric volume of this prodrug. The cross-docking approach corroborated experimental drug-displacement assays, indicating that the binding affinity of TFV and TAF might be impacted by the presence of different compounds bound to albumin. Overall, the weak binding capacity of albumin to TFV, TDF, and TAF is one of the main factors for the low residence time of these antiretrovirals in the human bloodstream; however, positive cooperativity for TAF and TDF was detected in the presence of some drugs, which might improve their residence time (pharmacokinetic profile).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Reverse Transcriptase InhibitorsTenofovirSerum Albumin, HumanProtein BindingAnti-HIV AgentsHumansThermodynamicsCalorimetryBinding SitesHIV InfectionsAlanineHIV Reverse Transcriptase

Stichwörter der Autor:innen

HIV reverse transcriptase inhibitorsHSA bindingin silico calculationsisothermal titration calorimetryprodrugsspectroscopy techniquestenofovir

Substanzen

Reverse Transcriptase InhibitorsTenofovirSerum Albumin, HumanAnti-HIV Agentstenofovir alafenamideAlanineHIV Reverse Transcriptase

Autor:innen und Institutionen

  • CQC-IMS, Department of Chemistry, University of Coimbra, Rua Larga, 3004-535 Coimbra, Portugal.
  • Laboratory of Immunopharmacology, Centro de Pesquisa, Inovação e Vigilância em COVID-19 e Emergências Sanitárias (CPIV), Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro 21040-361, RJ, Bra…

ORCID-Profile: Andreia Costa-Tuna, Otávio A Chaves, Zaida L Almeida, João Pina, Carlos Serpa

Förderung

  • Fundação para a Ciência e Tecnologia
  • Fundação para a Ciência e a Tecnologia (FCT—Portuguese Agency for Scientific Research)

Zitieren

APA

Costa-Tuna, A., Chaves, O. A., Almeida, Z. L., Cunha, R. S., Pina, J., & Serpa, C. (2024). Profiling the Interaction between Human Serum Albumin and Clinically Relevant HIV Reverse Transcriptase Inhibitors. Viruses. https://doi.org/10.3390/v16040491

Vancouver

Costa-Tuna A, Chaves OA, Almeida ZL, Cunha RS, Pina J, Serpa C. Profiling the Interaction between Human Serum Albumin and Clinically Relevant HIV Reverse Transcriptase Inhibitors. Viruses. 2024. doi:10.3390/v16040491

BibTeX
@article{CostaTuna2024,
  author = {Costa-Tuna, Andreia and Chaves, Otávio A and Almeida, Zaida L and Cunha, Rita S and Pina, João and Serpa, Carlos},
  title = {Profiling the Interaction between Human Serum Albumin and Clinically Relevant HIV Reverse Transcriptase Inhibitors},
  journal = {Viruses},
  year = {2024},
  doi = {10.3390/v16040491}
}
Kostenlos starten →